Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray plus stellate ganglion block for insomnia disorder
ChiCTR2400091578Phase 4Not yet recruiting
- Sponsor
- Guangzhou University of Chinese Medicine Third Affiliated Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Insomnia (2 arms), sponsored by Guangzhou University of Chinese Medicine Third Affiliated Hospital. Primary endpoint: Pittsburgh Sleep Quality Index at Day 90. Planned start May 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2400091578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091578.